We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
+0.4%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.91B
AUM Growth
-$33.5M
(-0.48%)
Cap. Flow
-$96.8M
Cap. Flow
% of AUM
-1.4%
Top 10 Holdings %
Top 10 Hldgs %
55.6%
Holding
295
New
67
Increased
47
Reduced
98
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$81.6M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
+$68M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
+$61.4M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$55.5M |
| 5 |
Keurig Dr Pepper
KDP
|
+$44.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$105M |
| 2 |
Organon & Co
OGN
|
+$75.3M |
| 3 |
EXAS
Exact Sciences
EXAS
|
+$69M |
| 4 |
Biogen
BIIB
|
+$57.7M |
| 5 |
Central Garden & Pet Co Class A
CENTA
|
+$53.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.29% |
| 2 | Consumer Staples | 5.94% |
| 3 | Technology | 4.58% |
| 4 | Consumer Discretionary | 4.41% |
| 5 | Communication Services | 2.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
AtriCure
ATRC
$2B
| – | – |
-5,899
| Closed | -$245K |
|
227
Avalo Therapeutics
AVTX
$997M
| – | – |
-18,396
| Closed | -$7.73M |
|
228
BlackSky Technology
BKSY
$1.03B
| – | – |
-1,392,835
| Closed | -$16.7M |
|
229
BioNTech
BNTX
$23.3B
| – | – |
-36,000
| Closed | -$4.48M |
|
230
Conagra Brands
CAG
$7.18B
| – | – |
-24,131
| Closed | -$906K |
|
|
CANF
231
Can-Fite BioPharma American Depositary Shares
CANF
$6.86M
| – | – |
-16,500
| Closed | -$756K |
|
|
232
Central Garden & Pet Co Class A
CENTA
$2.41B
| – | – |
-1,705,000
| Closed | -$53.3M |
|
233
CNS Pharmaceuticals
CNSP
$7.89M
| – | – |
-4
| Closed | -$124K |
|
234
CVS Health
CVS
$126B
| – | – |
-156,000
| Closed | -$11.6M |
|
235
Dine Brands
DIN
$453M
| – | – |
-5,569
| Closed | -$377K |
|
236
Dollar Tree
DLTR
$24.7B
| – | – |
-20,000
| Closed | -$2.87M |
|
|
DRRX
237
DELISTED
DURECT Corp
DRRX
| – | – |
-610,000
| Closed | -$2.76M |
|
238
Brinker International
EAT
$9.69B
| – | – |
-5,689
| Closed | -$216K |
|
239
eBay
EBAY
$49.4B
| – | – |
-20,588
| Closed | -$913K |
|
240
Edgewell Personal Care
EPC
$1.35B
| – | – |
-5,427
| Closed | -$230K |
|
241
First Horizon
FHN
$12.4B
| – | – |
-1,236,000
| Closed | -$22M |
|
242
GoDaddy
GDDY
$11.6B
| – | – |
-7,506
| Closed | -$583K |
|
243
Genprex
GNPX
$2.24M
| – | – |
-44
| Closed | -$1.77M |
|
244
Generac Holdings
GNRC
$12.8B
| – | – |
-48,000
| Closed | -$5.18M |
|
245
GT Biopharma
GTBP
$11.4M
| – | – |
-73,334
| Closed | -$1.21M |
|
246
Greenland Technologies Holding
GTEC
$14.3M
| – | – |
-343,974
| Closed | -$561K |
|
247
Hasbro
HAS
$12.9B
| – | – |
-437,500
| Closed | -$23.5M |
|
248
Home Depot
HD
$352B
| – | – |
-2,821
| Closed | -$833K |
|
249
iBio
IBIO
$69.5M
| – | – |
-26,282
| Closed | -$1.09M |
|
250
ImmunityBio
IBRX
$7.59B
| – | – |
-5,795,927
| Closed | -$10.5M |
|
Similar funds
CRC
RMDI
F
EW
O
DSC
ACM
PI
Armistice Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Armistice Capital held 295 positions worth $6.91B, down 0.48% from $6.94B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Armistice Capital's Q2 2023 filing shows 67 new, 47 increased, 98 reduced and 74 closed positions. Its largest new stake was Pfizer: 2,096,000 shares worth $76.9M. The largest sale was GSK, an estimated $105M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 44% a quarter earlier, followed by Consumer Staples and Technology.
- Armistice Capital's largest Q2 2023 buy was Pfizer: 2,096,000 shares worth $76.9M.
- Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2023, an estimated $55.5M increase.
- Armistice Capital's biggest Q2 2023 reduction was GSK, cutting an estimated $105M.
- Armistice Capital fully exited Organon & Co in Q2 2023, selling an estimated $75.3M.
- Armistice Capital's ten largest holdings make up 56% of its $6.91B portfolio in Q2 2023.
- Armistice Capital opened 67 new positions and closed 74 in Q2 2023.
- Armistice Capital's portfolio value fell 0.48% quarter-over-quarter to $6.91B.
Based on Armistice Capital's 13F filing for Q2 2023, filed 14 Aug 2023.